A detailed history of Prudential Financial Inc transactions in Arcellx, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 3,120 shares of ACLX stock, worth $242,049. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,120
Holding current value
$242,049
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$50.91 - $86.61 $158,839 - $270,223
3,120 New
3,120 $260,000
Q1 2024

May 14, 2024

BUY
$51.85 - $73.49 $180,645 - $256,039
3,484 New
3,484 $242,000

Others Institutions Holding ACLX

About Arcellx, Inc.


  • Ticker ACLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,819,200
  • Market Cap $3.4B
  • Description
  • Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...
More about ACLX
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.